{"id":"https://openalex.org/W2073099528","doi":"https://doi.org/10.2337/diacare.19.11.1200","title":"The Antidiabetogenic Effect of GLP-1 Is Maintained During a 7-Day Treatment Period and Improves Diabetic Dyslipoproteinemia in NIDDM Patients","display_name":"The Antidiabetogenic Effect of GLP-1 Is Maintained During a 7-Day Treatment Period and Improves Diabetic Dyslipoproteinemia in NIDDM Patients","alternate_titles":[],"publication_year":1996,"publication_date":"1996-11-01","ids":{"openalex":"https://openalex.org/W2073099528","doi":"https://doi.org/10.2337/diacare.19.11.1200","mag":"2073099528","pmid":"https://pubmed.ncbi.nlm.nih.gov/8908380"},"language":"en","primary_location":{"id":"doi:10.2337/diacare.19.11.1200","doi":"https://doi.org/10.2337/diacare.19.11.1200","is_oa":false,"landing_page_url":"https://doi.org/10.2337/diacare.19.11.1200","pdf_url":null,"source":{"id":"https://openalex.org/S49878492","display_name":"Diabetes Care","issn_l":"0149-5992","issn":["0149-5992","1935-5548"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320274","host_organization_name":"American Diabetes Association","host_organization_lineage":["https://openalex.org/P4310320274"],"host_organization_lineage_names":["American Diabetes Association"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes Care","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2073099528"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5082322134","display_name":"Lisa Juntti\u2010Berggren","orcid":"https://orcid.org/0000-0001-9690-4909","observed_orcids":["https://orcid.org/0000-0001-9690-4909"]},"institutions":[{"id":"https://openalex.org/I1335113835","display_name":"Karolinska University Hospital","ror":"https://ror.org/00m8d6786","country_code":"SE","type":"healthcare","lineage":["https://openalex.org/I1335113835"]},{"id":"https://openalex.org/I28166907","display_name":"Karolinska Institutet","ror":"https://ror.org/056d84691","country_code":"SE","type":"education","lineage":["https://openalex.org/I28166907"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Lisa Juntti-Berggren","raw_affiliation_strings":["Department of Molecular Medicine, Unit for Diabetes and Endocrinology, Karolinska Hospital, Karolinska Institute\u2008Stockholm, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Molecular Medicine, Unit for Diabetes and Endocrinology, Karolinska Hospital, Karolinska Institute\u2008Stockholm, Sweden","institution_ids":["https://openalex.org/I1335113835","https://openalex.org/I28166907"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064172190","display_name":"Jan Pigon","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1335113835","display_name":"Karolinska University Hospital","ror":"https://ror.org/00m8d6786","country_code":"SE","type":"healthcare","lineage":["https://openalex.org/I1335113835"]},{"id":"https://openalex.org/I28166907","display_name":"Karolinska Institutet","ror":"https://ror.org/056d84691","country_code":"SE","type":"education","lineage":["https://openalex.org/I28166907"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Jan Pigon","raw_affiliation_strings":["Department of Molecular Medicine, Unit for Diabetes and Endocrinology, Karolinska Hospital, Karolinska Institute\u2008Stockholm, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Molecular Medicine, Unit for Diabetes and Endocrinology, Karolinska Hospital, Karolinska Institute\u2008Stockholm, Sweden","institution_ids":["https://openalex.org/I1335113835","https://openalex.org/I28166907"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051598717","display_name":"Fredrik Karpe","orcid":"https://orcid.org/0000-0002-2751-1770","observed_orcids":["https://orcid.org/0000-0002-2751-1770"]},"institutions":[{"id":"https://openalex.org/I28166907","display_name":"Karolinska Institutet","ror":"https://ror.org/056d84691","country_code":"SE","type":"education","lineage":["https://openalex.org/I28166907"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Fredrik Karpe","raw_affiliation_strings":["Atherosclerosis Research Unit, King Gustaf V Research Institute, Karolinska Hospital, Karolinska Institute\u2008Stockholm, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Atherosclerosis Research Unit, King Gustaf V Research Institute, Karolinska Hospital, Karolinska Institute\u2008Stockholm, Sweden","institution_ids":["https://openalex.org/I28166907"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113476701","display_name":"Anders Hamsten","orcid":"https://orcid.org/0000-0002-0618-0538","observed_orcids":["https://orcid.org/0000-0002-0618-0538"]},"institutions":[{"id":"https://openalex.org/I28166907","display_name":"Karolinska Institutet","ror":"https://ror.org/056d84691","country_code":"SE","type":"education","lineage":["https://openalex.org/I28166907"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Anders Hamsten","raw_affiliation_strings":["Atherosclerosis Research Unit, King Gustaf V Research Institute, Karolinska Hospital, Karolinska Institute\u2008Stockholm, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Atherosclerosis Research Unit, King Gustaf V Research Institute, Karolinska Hospital, Karolinska Institute\u2008Stockholm, Sweden","institution_ids":["https://openalex.org/I28166907"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041450940","display_name":"M. Gutniak","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1335113835","display_name":"Karolinska University Hospital","ror":"https://ror.org/00m8d6786","country_code":"SE","type":"healthcare","lineage":["https://openalex.org/I1335113835"]},{"id":"https://openalex.org/I28166907","display_name":"Karolinska Institutet","ror":"https://ror.org/056d84691","country_code":"SE","type":"education","lineage":["https://openalex.org/I28166907"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Mark Gutniak","raw_affiliation_strings":["Department of Molecular Medicine, Unit for Diabetes and Endocrinology, Karolinska Hospital, Karolinska Institute\u2008Stockholm, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Molecular Medicine, Unit for Diabetes and Endocrinology, Karolinska Hospital, Karolinska Institute\u2008Stockholm, Sweden","institution_ids":["https://openalex.org/I1335113835","https://openalex.org/I28166907"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068506691","display_name":"Louis Vignati","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Louis Vignati","raw_affiliation_strings":["Lilly Research Laboratories, Lilly Corporate Center\u2008Indianapolis, Indiana"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lilly Research Laboratories, Lilly Corporate Center\u2008Indianapolis, Indiana","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5042723115","display_name":"Suad Efendi\u0107","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1335113835","display_name":"Karolinska University Hospital","ror":"https://ror.org/00m8d6786","country_code":"SE","type":"healthcare","lineage":["https://openalex.org/I1335113835"]},{"id":"https://openalex.org/I28166907","display_name":"Karolinska Institutet","ror":"https://ror.org/056d84691","country_code":"SE","type":"education","lineage":["https://openalex.org/I28166907"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Suad Efendic","raw_affiliation_strings":["Department of Molecular Medicine, Unit for Diabetes and Endocrinology, Karolinska Hospital, Karolinska Institute\u2008Stockholm, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Molecular Medicine, Unit for Diabetes and Endocrinology, Karolinska Hospital, Karolinska Institute\u2008Stockholm, Sweden","institution_ids":["https://openalex.org/I1335113835","https://openalex.org/I28166907"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":3.6204,"has_fulltext":false,"cited_by_count":66,"citation_normalized_percentile":{"value":0.9301536,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":86,"max":97},"biblio":{"volume":"19","issue":"11","first_page":"1200","last_page":"1206"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10560","display_name":"Diabetes Management and Research","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10027","display_name":"Diabetes, Cardiovascular Risks, and Lipoproteins","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/glucagon-like-peptide-1","display_name":"glucagon-like peptide-1","score":0.9729999899864197},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.902999997138977},{"id":"https://openalex.org/keywords/insulin-dose-reduction","display_name":"insulin dose reduction","score":0.5630000233650208},{"id":"https://openalex.org/keywords/postprandial-blood-glucose","display_name":"postprandial blood glucose","score":0.843999981880188},{"id":"https://openalex.org/keywords/vldl-triglycerides","display_name":"VLDL triglycerides","score":0.9359999895095825},{"id":"https://openalex.org/keywords/ldl-particle-size","display_name":"LDL particle size","score":0.984000027179718},{"id":"https://openalex.org/keywords/lipoprotein-lipase","display_name":"lipoprotein lipase","score":0.9710000157356262},{"id":"https://openalex.org/keywords/hepatic-lipase","display_name":"hepatic lipase","score":1.0},{"id":"https://openalex.org/keywords/intensive-insulin-therapy","display_name":"intensive insulin therapy","score":0.621999979019165},{"id":"https://openalex.org/keywords/lipoprotein-metabolism","display_name":"lipoprotein metabolism","score":0.44999998807907104}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.90725177526474},{"id":"https://openalex.org/C2779306644","wikidata":"https://www.wikidata.org/wiki/Q2002370","display_name":"Insulin","level":2,"score":0.8360521793365479},{"id":"https://openalex.org/C2778199505","wikidata":"https://www.wikidata.org/wiki/Q2992990","display_name":"Postprandial","level":3,"score":0.8279788494110107},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.8251407742500305},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.7409448027610779},{"id":"https://openalex.org/C2778537899","wikidata":"https://www.wikidata.org/wiki/Q254034","display_name":"Bedtime","level":2,"score":0.6916140913963318},{"id":"https://openalex.org/C2776398474","wikidata":"https://www.wikidata.org/wiki/Q424611","display_name":"Glucagon-like peptide-1","level":4,"score":0.6082200407981873},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.6006658673286438},{"id":"https://openalex.org/C2778345441","wikidata":"https://www.wikidata.org/wiki/Q6460735","display_name":"Meal","level":2,"score":0.5590737462043762},{"id":"https://openalex.org/C2778563252","wikidata":"https://www.wikidata.org/wiki/Q170617","display_name":"Glucagon","level":3,"score":0.5202868580818176},{"id":"https://openalex.org/C2778804033","wikidata":"https://www.wikidata.org/wiki/Q1929845","display_name":"NPH insulin","level":5,"score":0.5158745050430298},{"id":"https://openalex.org/C70818257","wikidata":"https://www.wikidata.org/wiki/Q502671","display_name":"Metabolic control analysis","level":3,"score":0.4197562038898468},{"id":"https://openalex.org/C2780668416","wikidata":"https://www.wikidata.org/wiki/Q202758","display_name":"Hypoglycemia","level":3,"score":0.333152711391449},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.30129218101501465},{"id":"https://openalex.org/C2779920387","wikidata":"https://www.wikidata.org/wiki/Q417317","display_name":"Insulin glargine","level":4,"score":0.11177635192871094}],"mesh":[{"descriptor_ui":"D001786","descriptor_name":"Blood Glucose","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D002096","descriptor_name":"C-Peptide","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005934","descriptor_name":"Glucagon","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D006442","descriptor_name":"Glycated Hemoglobin","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006951","descriptor_name":"Hyperlipoproteinemias","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D006951","descriptor_name":"Hyperlipoproteinemias","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D006951","descriptor_name":"Hyperlipoproteinemias","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D007328","descriptor_name":"Insulin","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D007328","descriptor_name":"Insulin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D008076","descriptor_name":"Cholesterol, HDL","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D008078","descriptor_name":"Cholesterol, LDL","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D008079","descriptor_name":"Lipoproteins, VLDL","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010446","descriptor_name":"Peptide Fragments","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D011498","descriptor_name":"Protein Precursors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D013997","descriptor_name":"Time Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014280","descriptor_name":"Triglycerides","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D052216","descriptor_name":"Glucagon-Like Peptide 1","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.2337/diacare.19.11.1200","doi":"https://doi.org/10.2337/diacare.19.11.1200","is_oa":false,"landing_page_url":"https://doi.org/10.2337/diacare.19.11.1200","pdf_url":null,"source":{"id":"https://openalex.org/S49878492","display_name":"Diabetes Care","issn_l":"0149-5992","issn":["0149-5992","1935-5548"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320274","host_organization_name":"American Diabetes Association","host_organization_lineage":["https://openalex.org/P4310320274"],"host_organization_lineage_names":["American Diabetes Association"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes Care","raw_type":"journal-article"},{"id":"pmid:8908380","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/8908380","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes care","raw_type":"Clinical Trial"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2103960782","https://openalex.org/W2042845313","https://openalex.org/W2163892210","https://openalex.org/W7217932570","https://openalex.org/W2000465889","https://openalex.org/W1992966015","https://openalex.org/W2126797308","https://openalex.org/W1997792880","https://openalex.org/W1992412433","https://openalex.org/W1997129422"],"abstract_inverted_index":{"OBJECTIVE:":[0],"To":[1],"investigate":[2],"the":[3,37,43,107,111,114,138,145,164,168,200,203,209,216,238,245,253,260,310,328,334,352,369,379],"long-term":[4],"antidiabetogenic":[5,335],"effect":[6,210,336,343,393],"of":[7,42,46,116,150,167,205,211,232,262,275,337,381,394],"glucagon-like":[8],"peptide":[9],"1":[10,27],"(GLP-1)":[11],"and":[12,53,67,91,182,197,228,264,320],"its":[13],"influence":[14],"on":[15,49],"diabetic":[16],"dyslipoproteinemia,":[17],"patients":[18,34,353,387],"with":[19,23,65,80,130,132,163,388],"NIDDM":[20,340],"were":[21,48,58,94,127,175,257],"treated":[22],"GLP-1":[24,74,97,135,190,212,249,300,338,395,405],"subcutaneously":[25],"for":[26,199,412],"week.":[28,240],"RESEARCH":[29],"DESIGN":[30],"AND":[31],"METHODS:":[32],"Twelve":[33],"participated":[35],"in":[36,141,202,220,252,259,283,309,327,339,386],"study.":[38,108],"The":[39,230,267,302],"1st":[40,239],"week":[41,247],"study,":[44],"all":[45],"them":[47],"intensive":[50],"insulin":[51,82,101,133,159,173,195,286,363],"treatment":[52,71,131,360],"from":[54,83,272],"day":[55,84,180],"8,":[56],"four":[57],"randomized":[59],"to":[60,69,86,120,192,277,285,291,366,377],"a":[61,70,122,273],"control":[62,311],"group":[63,72],"continuing":[64],"insulin,":[66,118],"eight":[68],"where":[73],"was":[75,104,154,187,213,250,297,316,323,344],"given":[76,96,105,119],"at":[77,98,102,179,226],"meals":[78],"together":[79],"regular":[81,117],"8":[85],"12.":[87],"On":[88],"days":[89],"13":[90],"14,":[92,183],"they":[93],"only":[95],"meals.":[99],"NPH":[100],"bedtime":[103],"throughout":[106],"RESULTS:":[109],"In":[110,161],"GLP-1-treated":[112,329],"patients,":[113],"doses":[115],"keep":[121],"satisfactory":[123],"blood":[124,142,223],"glucose":[125,143,224],"control,":[126],"reduced":[128,324],"compared":[129],"only.":[134],"virtually":[136],"inhibited":[137],"early":[139],"increase":[140,149],"after":[144,299],"meals,":[146],"whereas":[147],"an":[148,157,391,410],"approximately":[151],"2":[152],"mmol":[153],"seen":[155,298],"during":[156,237,244,346,358],"optimized":[158],"treatment.":[160,254,287,301],"agreement":[162],"short":[165],"half-life":[166],"peptide,":[169],"2-h":[170],"postprandial":[171],"plasma":[172],"levels":[174,261],"significantly":[176],"decreased":[177,235,317],"both":[178],"12":[181],"suggesting":[184],"that":[185,351,404],"there":[186],"not":[188,307,355],"enough":[189],"left":[191],"stimulate":[193],"endogenous":[194],"release":[196],"compensate":[198],"decrease":[201,242],"dose":[204],"exogenous":[206],"insulin.":[207],"Therefore,":[208],"lost":[214],"before":[215],"next":[217],"meal,":[218],"resulting":[219],"increased":[221,271,368],"preprandial":[222],"values":[225],"lunch":[227],"dinner.":[229],"concentration":[231],"VLDL":[233],"triglycerides":[234],"already":[236],"This":[241,342],"persisted":[243],"2nd":[246],"when":[248],"included":[251],"No":[255],"changes":[256],"observed":[258],"LDL":[263,268,303,371],"HDL":[265],"cholesterol.":[266],"particle":[269,304,372],"diameter":[270],"mean":[274,370],"22.3":[276],"22.6":[278],"nm":[279,293],"(P":[280,294],"<":[281,295],"0.01)":[282],"response":[284],"A":[288],"further":[289],"increment":[290],"22.9":[292],"0.05)":[296],"size":[305],"did":[306,354],"change":[308],"group.":[312,330],"Lipoprotein":[313],"lipase":[314,322],"activity":[315],"by":[318,325],"27%":[319],"hepatic":[321],"13%":[326],"CONCLUSIONS:":[331],"We":[332],"confirm":[333],"patients.":[341],"maintained":[345],"7":[347],"days,":[348],"which":[349,374],"implies":[350],"develop":[356],"tolerance":[357],"this":[359,399],"period.":[361],"Intensive":[362],"treatment,":[364],"leading":[365],"normotriglyceridemia,":[367],"diameter,":[373],"is":[375,396],"likely":[376],"lower":[378],"risk":[380],"future":[382],"coronary":[383],"heart":[384],"disease":[385],"NIDDM.":[389,414],"Furthermore,":[390],"additive":[392],"indicated.":[397],"Hence,":[398],"study":[400],"gives":[401],"additional":[402],"evidence":[403],"may":[406],"be":[407],"useful":[408],"as":[409],"agent":[411],"treating":[413]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2073099528","counts_by_year":[{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":4},{"year":2014,"cited_by_count":1},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
